A detailed history of Prosight Management, LP transactions in Adc Therapeutics Sa stock. As of the latest transaction made, Prosight Management, LP holds 9,636,237 shares of ADCT stock, worth $19.6 Million. This represents 8.15% of its overall portfolio holdings.

Number of Shares
9,636,237
Previous 9,570,000 0.69%
Holding current value
$19.6 Million
Previous $30.2 Million 0.37%
% of portfolio
8.15%
Previous 9.45%

Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$2.59 - $4.01 $171,553 - $265,610
66,237 Added 0.69%
9,636,237 $30.4 Million
Q2 2024

Aug 14, 2024

BUY
$2.55 - $5.09 $6.43 Million - $12.8 Million
2,519,700 Added 35.74%
9,570,000 $30.2 Million
Q1 2024

May 15, 2024

BUY
$1.66 - $5.29 $960,310 - $3.06 Million
578,500 Added 8.94%
7,050,300 $31.7 Million
Q4 2023

Feb 14, 2024

BUY
$0.47 - $1.79 $502,786 - $1.91 Million
1,069,759 Added 19.8%
6,471,800 $10.7 Million
Q3 2023

Nov 14, 2023

SELL
$0.72 - $2.37 $130,938 - $431,005
-181,859 Reduced 3.26%
5,402,041 $4.86 Million
Q2 2023

Aug 14, 2023

BUY
$1.9 - $2.66 $4.42 Million - $6.19 Million
2,326,540 Added 71.42%
5,583,900 $12 Million
Q1 2023

May 12, 2023

BUY
$1.92 - $5.45 $5.36 Million - $15.2 Million
2,794,050 Added 603.06%
3,257,360 $6.35 Million
Q4 2022

Feb 14, 2023

BUY
$2.87 - $5.24 $619,001 - $1.13 Million
215,680 Added 87.1%
463,310 $1.78 Million
Q3 2022

Nov 14, 2022

BUY
$4.66 - $10.31 $1.15 Million - $2.55 Million
247,630 New
247,630 $1.19 Million

Others Institutions Holding ADCT

About ADC Therapeutics SA


  • Ticker ADCT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 77,645,296
  • Market Cap $158M
  • Description
  • ADC Therapeutics SA, a commercial-stage biotechnology company, develops antibody drug conjugates (ADC) for patients suffering from hematological malignancies and solid tumors. Its flagship product ZYNLONTA that is in Phase II clinical trial for the treatment of relapsed or refractory diffuse large B-cell lymphoma (DLBCL) and follicular lymphoma;...
More about ADCT
Track This Portfolio

Track Prosight Management, LP Portfolio

Follow Prosight Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Prosight Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Prosight Management, LP with notifications on news.